AASHISH G SAMAT
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NEW BRITAIN, CT NPI 1912155300
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism CT Novo Nordisk AS All categories
General Payments — all program years on this page
$2,794.78
- Category: General Payments
- Program years: PY2018–2024
- Record count: 60
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $338.77 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.77 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $249.62 | 5 |
| DEXCOM, INC. | $70.57 | 3 |
| Amgen Inc. | $18.58 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096756897 | Novo Nordisk Inc | $113.58 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096774755 | Novo Nordisk Inc | $6.28 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096898197 | Novo Nordisk Inc | $115.25 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096912382 | Novo Nordisk Inc | $7.85 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096985550 | Novo Nordisk Inc | $6.66 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111696800 | Amgen Inc. | $18.58 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153275910 | Dexcom, Inc. | $23.38 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153275912 | Dexcom, Inc. | $23.61 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153275914 | Dexcom, Inc. | $23.58 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.